Biotech News

While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, some say the U.S. drugmaker should consider targets more focussed on biotechnology, a strategy that has paid off for Merck & Co Although Pfizer is conducting trials of promising products - including breast cancer drug palbociclib and vaccines ... (more)

Wockhardt Ltd, which denied stake-sale rumours on Friday following an unusual spurt in its stock price, is in the final stages of receiving much-awaited regulatory approvals for its Chikalthana unit in Maharashtra.

Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.

Three people accused of scheming to manufacture and ship salmonella-tainted peanuts that killed nine people and sickened more than 700 are set to go to trial this week in Georgia.

Merck has kicked off its second year of its five year project to provide European Accredited Clinical Diabetes Management course for medical and pharmacy students in African Universities by introducing E-Learning.

GM is now a term loaded with baggage. Scientists must allow for people's objections to show the public there's nothing "spooky" about it WITH food security firmly on the international agenda, there's a growing appetite to look again at the opportunities promised by agricultural biotechnology.

The second, accepted but not yet published by Theoretical and Applied Genetics, was done with several of the professional scientists mentoring the P2EP interns.

The Elizabeth Glaser Pediatric AIDS Foundation applauds the new licensing agreement between the Medicines Patent Pool and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate , a promising new HIV medication.

The government has issued its first national estimate for Lou Gehrig's disease, confirming the devastating disease is rare.

In this , Tuesday, Feb. 11, 2014, file photo, Federal Reserve Chair Janet Yellen listens while testifying on Capitol Hill in Washington.

Merck & Co., which is reorganizing to slash $2.5 billion in costs and 8,500 workers, has informed Pennsylvania officials that it will cut 600 jobs at facilities in North Wales and Lansdale.

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

Le CMUH europen adopte une opinion positive envers le Zydelig de Gilead pour le traitement de la leucmie lymphode chronique et du lymphome folliculaire )--Gilead Sciences, Inc. a annoncA© aujourd'hui que le ComitA© des mA©dicaments A usage humain , le comitA© scientifique de l'Agence europA©e... )--Gilead Sciences, Inc.

"Our patients are predominently mice." That's how the conversation began with Daniel Bradley, the associate director at Takeda Pharmaceuticals International Co.

A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza has been recommended for approval in Europe, in an important boost for the Danish company.

Drugmaker AbbVie Inc.'s second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira.

A lab crucial to diagnosing cases of drug-resistant tuberculosis at the Centers for Disease Control and Prevention has reopened, according to the CDC.

Unacceptably low numbers of teens are getting vaccinated for the human papillomavirus, or HPV, which protects against cervical, throat and mouth cancers, according to the Centers for Disease Control and Prevention.

GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.

Bristol-Myers Squibb Co. will create a Redwood City research hub for drugs that stimulate the immune system to fight cancer.